State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature

Journal of Neuro-Oncology

Volumn 128, Issue 3, 2016, Pages 387-394

  Veldhuijzen van Zanten, Sophie E M ^a   Cruz, Ofelia ^b   Kaspers, Gertjan J L ^a,c   Hargrave, Darren R ^d   van Vuurden, Dannis G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c Department of Radiation Oncology   (Netherlands)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Diffuse Intrinsic Pontine Glioma (DIPG); Pediatric oncology; Quality of life (QoL); Side effects; Steroids

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; STEROID; ANTINEOPLASTIC AGENT;

CANCER PATIENT; CHILD HEALTH CARE; CUSHING SYNDROME; DEPRESSION; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG USE; EDEMA; EVIDENCE BASED MEDICINE; FOOD ADDICTION; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; INSOMNIA; MOOD DISORDER; MUSCLE ATROPHY; OBESITY; OPTIMAL DRUG DOSE; PERSONALITY DISORDER; PONTINE GLIOMA; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK BENEFIT ANALYSIS; SKIN DISEASE; STEROID THERAPY; TREATMENT DURATION; BRAIN STEM TUMOR; GLIOMA; INTERNATIONAL COOPERATION;

ANTINEOPLASTIC AGENTS; BRAIN STEM NEOPLASMS; GLIOMA; HEALTH PERSONNEL; HUMANS; INTERNATIONALITY; STEROIDS; SURVEYS AND QUESTIONNAIRES;

EID: 84968546883     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-016-2141-x     Document Type: Review

References (24)

1. Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248. doi:10.1016/S1470-2045(06)70615-5
2. Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol 2:205. doi:10.3389/fonc.2012.00205
3. Glaser A, Buxton N, Walker D (1997) Corticosteroids in the management of central nervous system tumours. Arch Dis Child 76:76–78. doi:10.1136/adc.76.1.76
4. Chemotherapy Standardisation Group (2008) Estimation of body-surface area in infants and children. Children’s Cancer and Leukaemia Group. http://www.ouh.nhs.uk/oxparc/professionals/documents/Body-surfaceareaCCLGChart1.pdf. Accessed 12 Jan 2016
5. Schmid UD, Seiler RW (1986) Management of obstructive hydrocephalus secondary to posterior fossa tumors by steroids and subcutaneous ventricular catheter reservoir. J Neurosurg 65:649–653. doi:10.3171/jns.1986.65.5.0649
6. Freeman CR, Krischer J, Sanford RA, Burger PC, Cohen M, Norris D (1988) Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 15:311–318
7. Freeman CR, Krischer J, Sanford RA, Cohen ME, Burger PC, Kun L et al (1991) Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. Cancer 68:474–481
8. Toftegaard M, Knudsen F (1995) Massive vasopressin-resistant polyuria induced by dexamethasone. Intensive Care Med 21:238–240
9. Wolff JE, Hauch H, Kühl J, Egeler RM, Jürgens H (1998) Dexamethasone increases hepatotoxicity of MTX in children with brain tumors. Anticancer Res 18:2895–2899
10. Mursch K, Buhre W, Behnke-Mursch J, Markakis E (2000) Peroperative cardiovascular stability during brainstem surgery. The use of high-dose methylprednisolone compared to dexamethasone. A retrospective analysis. Acta Anaesthesiol Scand 44:378–382
11. Edelbauer M, Gerstmayr M, Loibichler C, Jost E, Huemer M (2002) Glucocorticoids enhance interleukin-4 production to neo-antigen (hyaluronidase) in children immunocompromised with cytostatic drugs. Pediatr Allergy Immunol 13:375–380
12. Mallur PS, Wisoff JH, Lalwani AK (2008) Steroid responsive fluctuating sensorineural hearing loss due to juvenile pilocytic astrocytoma involving the cerebellopontine angle. Int J Pediatr Otorhinolaryngol 72:529–534
13. Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM et al (2010) Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 28:4762–4768. doi:10.1200/JCO.2010.30.3545
14. Meyzer C, Dhermain F, Ducreux D, Habrand JL, Varlet P, Sainte-Rose C et al (2010) A case report of pseudoprogression followed by complete remission after proton-beam irradiation for a low-grade glioma in a teenager: the value of dynamic contrast-enhanced MRI. Radiat Oncol 5:9. doi:10.1186/1748-717X-5-9
15. Beltran C, Sharma S, Merchant TE (2011) Role of adaptive radiation therapy for pediatric patients with diffuse pontine glioma. J Appl Clin Med Phys 12:3421
16. Wheeler H, Black J, Webb S, Shen H (2011) Dehiscence of corticosteroid-induced abdominal striae in a 14-year-old boy treated with bevacizumab for recurrent glioblastoma. J Child Neurol 27:927–929
17. Yamasaki F, Nakamura K, Sugiyama K, Kobayashi M, Kurisu K (2012) A survey of pediatricians’ and neurosurgeons’ policies regarding the use of corticosteroids in children with cancer and brain tumors. No Shinkei Geka 40:607–616
18. Liu AK, Macy ME, Foreman NK (2009) Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys 75:1148–1154
19. Grossman SA, Ye X, Lesser G, Sloan A, Carraway H, Desideri S, Piantadosi S (2011) Immunosuppression in patients with high grade gliomas treated with radiation and temozolomide. Clin Cancer Res 17:5473–5480. doi:10.1016/j.biotechadv.2011.08.021.Secreted
20. Janssen G, Bode U, Breu H, Dohrn B, Engelbrecht V, Göbel U (2000) Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors. Klin Pädiatrie 212:189–195. doi:10.1055/s-2000-9676
21. Villalona-Calero MA, Eckardt J, Burris H, Kraynak M, Fields-Jones S, Bazan C et al (1998) A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema. Ann Oncol 9:71–77
22. Moliterno JA, Henry E, Pannullo SC (2009) Corticorelin acetate injections for the treatment of peritumoral brain edema. Expert Opin Investig Drugs 18:1413–1419. doi:10.1517/13543780903190689
23. Fontanilla HP, Pinnix CC, Ketonen LM, Woo SY, Vats TS, Rytting ME et al (2012) Palliative reirradiation for progressive diffuse intrinsic pontine glioma. Am J Clin Oncol 35:51–57. doi:10.1097/COC.0b013e318201a2b7
24. Oxford Centre for Evidence-based Medicine (2009) Levels of evidence. Centre for Evidence-based Medicine. http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed 12 Jan 2016